Amneal Pharmaceuticals, Inc. (AMRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.22 | +157.9% |
| 2024 | $-0.38 | +20.8% |
| 2023 | $-0.48 | +44.2% |
| 2022 | $-0.86 | -1328.6% |
| 2021 | $0.07 | -88.5% |
| 2020 | $0.61 | +122.3% |
| 2019 | $-2.74 | -1612.5% |
| 2018 | $-0.16 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.22 | +157.9% |
| 2024 | $-0.38 | +20.8% |
| 2023 | $-0.48 | +44.2% |
| 2022 | $-0.86 | -1328.6% |
| 2021 | $0.07 | -88.5% |
| 2020 | $0.61 | +122.3% |
| 2019 | $-2.74 | -1612.5% |
| 2018 | $-0.16 | — |